Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis.

Author
:
Z Zhang
Y Zhang
G Chen
S Hong
Y Yang
W Fang
F Luo
X Chen
Y Ma
Y Zhao
J Zhan
C Xue
X Hou
T Zhou
S Ma
F Gao
Y Huang
L Chen
N Zhou
H Zhao
L Zhang
Abstract
:

The current antiemetic prophylaxis for patients treated with highly emetogenic chemotherapy (HEC) included the olanzapine-based triplet and neurokinin-1 receptor antagonists (NK-1RAs)-based triplet. However, which one shows better antiemetic effect remained unclear.
Year of Publication
:
2018
Journal
:
The oncologist
Date Published
:
2018
ISSN Number
:
1083-7159
URL
:
http://theoncologist.alphamedpress.org/cgi/pmidlookup?view=long&pmid=29330211
DOI
:
10.1634/theoncologist.2017-0378
Short Title
:
Oncologist
Download citation